[go: up one dir, main page]

FR2924712B1 - Derives du gossypol et de l'apogossypol, leurs preparations et leurs applications - Google Patents

Derives du gossypol et de l'apogossypol, leurs preparations et leurs applications

Info

Publication number
FR2924712B1
FR2924712B1 FR0708518A FR0708518A FR2924712B1 FR 2924712 B1 FR2924712 B1 FR 2924712B1 FR 0708518 A FR0708518 A FR 0708518A FR 0708518 A FR0708518 A FR 0708518A FR 2924712 B1 FR2924712 B1 FR 2924712B1
Authority
FR
France
Prior art keywords
apogossypol
gossypol
preparations
derivatives
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0708518A
Other languages
English (en)
Other versions
FR2924712A1 (fr
Inventor
Jacques Mortier
Anne Sophie Castanet
Nguyet Trang Thanh Chau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Le Mans Universite
University of Maine System
Original Assignee
Le Mans Universite
University of Maine System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Le Mans Universite, University of Maine System filed Critical Le Mans Universite
Priority to FR0708518A priority Critical patent/FR2924712B1/fr
Priority to CA2708290A priority patent/CA2708290A1/fr
Priority to PCT/FR2008/052216 priority patent/WO2009080949A1/fr
Priority to EP08865841A priority patent/EP2231573A1/fr
Priority to US12/746,339 priority patent/US8455540B2/en
Publication of FR2924712A1 publication Critical patent/FR2924712A1/fr
Application granted granted Critical
Publication of FR2924712B1 publication Critical patent/FR2924712B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/30Preparation of ethers by reactions not forming ether-oxygen bonds by increasing the number of carbon atoms, e.g. by oligomerisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/353Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by isomerisation; by change of size of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0708518A 2007-12-06 2007-12-06 Derives du gossypol et de l'apogossypol, leurs preparations et leurs applications Expired - Fee Related FR2924712B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0708518A FR2924712B1 (fr) 2007-12-06 2007-12-06 Derives du gossypol et de l'apogossypol, leurs preparations et leurs applications
CA2708290A CA2708290A1 (fr) 2007-12-06 2008-12-05 Derives du gossypol et de l'apogossypol, leurs preparations et leurs applications
PCT/FR2008/052216 WO2009080949A1 (fr) 2007-12-06 2008-12-05 Dérivés du gossypol et de l'apogossypol, leurs préparations et leurs applications
EP08865841A EP2231573A1 (fr) 2007-12-06 2008-12-05 Dérivés du gossypol et de l'apogossypol, leurs préparations et leurs applications
US12/746,339 US8455540B2 (en) 2007-12-06 2008-12-05 Gossypol and apogossypol derivatives, preparation thereof and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0708518A FR2924712B1 (fr) 2007-12-06 2007-12-06 Derives du gossypol et de l'apogossypol, leurs preparations et leurs applications

Publications (2)

Publication Number Publication Date
FR2924712A1 FR2924712A1 (fr) 2009-06-12
FR2924712B1 true FR2924712B1 (fr) 2012-12-21

Family

ID=39563297

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0708518A Expired - Fee Related FR2924712B1 (fr) 2007-12-06 2007-12-06 Derives du gossypol et de l'apogossypol, leurs preparations et leurs applications

Country Status (5)

Country Link
US (1) US8455540B2 (fr)
EP (1) EP2231573A1 (fr)
CA (1) CA2708290A1 (fr)
FR (1) FR2924712B1 (fr)
WO (1) WO2009080949A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102516071A (zh) * 2011-12-16 2012-06-27 武汉大学 具有抗禽流感病毒活性的手性棉酚酸及其制备方法
WO2013121428A1 (fr) * 2012-02-15 2013-08-22 Carmel-Haifa University Economic Corporation Ltd. Antagonistes de bcl-2 et leurs utilisations dans l'induction de l'apoptose
CN103265560B (zh) * 2013-05-17 2016-05-04 中国科学院上海高等研究院 棉酚/棉酮衍生物及其制备方法和抗肿瘤药物中的应用
JPWO2015199141A1 (ja) * 2014-06-26 2017-04-20 国立大学法人群馬大学 発光性・半導体性能を発現するクマリン系縮環化合物およびその製造方法
RU2766222C2 (ru) * 2017-12-26 2022-02-10 Общество с ограниченной ответственностью "НИАРМЕДИК ФАРМА" Несимметричные производные полифенолов динафталинового ряда, способ их получения и применение
CN110559449B (zh) * 2019-10-22 2022-09-02 长治医学院 一种聚棉酚前药胶束及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7432304B2 (en) * 2001-05-30 2008-10-07 The Regents Of The University Of Michigan Small molecule antagonists of Bcl-2 family proteins
US7304161B2 (en) * 2003-02-10 2007-12-04 Intrexon Corporation Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
PL1653943T6 (pl) 2003-06-25 2009-02-27 The Burnham Inst La Jolla Pochodne katecholu do leczenia raka

Also Published As

Publication number Publication date
US20100331398A1 (en) 2010-12-30
EP2231573A1 (fr) 2010-09-29
WO2009080949A1 (fr) 2009-07-02
FR2924712A1 (fr) 2009-06-12
CA2708290A1 (fr) 2009-07-02
US8455540B2 (en) 2013-06-04

Similar Documents

Publication Publication Date Title
EP1973405A4 (fr) Derives d'hydroxyalkymarylamide
DE602007010981D1 (de) Cycloalkylaminsubstituierte isochinolin- und isochinolinonderivate
EP2023941A4 (fr) Agents de réticulation de protéine, méthodes de réticulation et leurs applications
FR2888850B1 (fr) Nouveaux anticorps anti-igf-ir et leurs applications
DK2046715T5 (da) Substituerede 1,3-diphenylpropanderivater, præparater og anvendelser deraf
CY2014026I1 (el) Συνθεσεις και χρησεις για θεραπεια σκληρυνσης κατα πλακας
BRPI0806941A2 (pt) Implementos de higiene bucal que têm elementos flexíveis, e métodos de produção dos mesmos
FR2911604B1 (fr) Derives de n-(heteroaryl-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
BRPI0811806A2 (pt) "absorvente higiênico alongado"
EP1976511A4 (fr) Derives d'arylamide fluore
CR10229A (es) Derivados de 1,2,4,5,-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
EP2377848A4 (fr) Dérivé d'arginine et produit cosmétique le comportant
FR2882062B1 (fr) Vecteurs d'expression stable et de longue duree de sirna et leurs applications
EP2252669A4 (fr) Composition de type azéotrope de 1,1,1-trifluoro-3-chloropropène et d acétate de méthyle
FR2921926B1 (fr) Derives de quinazolinedione,leur preparation et leurs applications therapeutiques.
EP2475649A4 (fr) Dérivé d'indénone et composition pharmaceutique le comprenant
FR2882054B1 (fr) Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique
EP2479216A4 (fr) Emulsion et agent de démoulage comportant l'émulsion
FR2924712B1 (fr) Derives du gossypol et de l'apogossypol, leurs preparations et leurs applications
BRPI0818121A2 (pt) diespiro 1,2,4-trioxolano e seus métodos de fabricação e utilização
FR2917413B1 (fr) Derives de 7-alkynyl-1,8-naphthyridones, leur preparation et leur application en therapeutique
FR2944282B1 (fr) Derives de quinazolinedione, leur preparation et leurs diverses applications therapeutiques
EP2440055A4 (fr) Dérivés de la styryl-triazine et leurs applications thérapeutiques
FR2920774B1 (fr) Nouveaux derives de n-phenul acatamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contentant
SMT201400097B (it) Derivati di 2 piridin-2-il-pirazol-3(2H)-one, loropreparazione e loro applicazione in campo terapeu tico come attivatori di hif

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

ST Notification of lapse

Effective date: 20170831